AI處方合規性自動審核工具

首頁

AI 提示詞列表

醫療健康

處方審核助手

${:__('collect %s',處方審核助手)}$

醫療健康

利用AI技術輔助藥師進行處方前置審核，識別潛在的藥物相互作用、劑量異常及禁忌症，提升用藥安全與效率。

提示內容

複製

Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.

複製

請扮演資深臨床藥師，對以下模擬處方進行合規性審查：患者為65歲男性，診斷為高血壓2級伴輕度腎功能不全（eGFR 45ml/min），當前用藥包括氨氯地平5mg qd、阿斯匹林100mg qd及布洛芬400mg tid（用於骨關節炎疼痛）。請分析該處方中是否存在藥物-疾病禁忌、藥物-藥物相互作用或劑量調整需求，特別是非類固醇抗炎藥在腎功能不全患者中的使用風險，並給出具體的調整建議或替代方案，確保用藥安全且符合臨床指南。

複製

分享點擊複製鏈接

評論 (0)

0/300

提交

推薦

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.

處方審核助手

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.

處方審核助手

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.

處方審核助手

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's hepatic and renal function status. Identify any risk points based on the latest clinical guidelines, and finally provide adjustment suggestions or confirm safety, ensuring the output is concise and clinically actionable.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions to ensure patient safety.